LRMR270219C00005000
LRMR Feb 19 2027 5.00 Call
optionOPRA
EODOct 21, 2026
0.10USD-60.000%(-0.15)10Vol494OI
Loading…
Underlying
Underlying Price
$2.24
Type
Call
Strike
5
Expiration
Feb 19, 2027
DTE
115d
Moneyness
OTM
Intrinsic
$0.00
LRMR 5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Nov 20, 2026 | 24d | $0.05 | +0.00% | 2 | 574 |
| Dec 18, 2026 | 52d | $0.05 | -44.44% | 3 | 160 |
| Jan 15, 2027 | 80d | $0.10 | +42.86% | 122 | 763 |
| Feb 19, 2027 | 115d | $0.10 | -60.00% | 10 | 494 |
| May 21, 2027 | 206d | $0.20 | -78.49% | 18 | 21 |
LRMR Profile
larimar therapeutics, inc. (nasdaq:lrmr), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. the company's lead compound, cti-1601, is currently being evaluated in a phase 1 clinical program as a potential treatment for friedreich's ataxia, a rare and progressive genetic disease. larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. for more information, please visit: https://larimartx.com.